ArticleJournal of family medicine and primary care2019

Will controlled release mebeverine be able to surpass placebo in treatment of diarrhoea predominant irritable bowel syndrome?

Dwaipayan Sarathi Chakraborty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.